KANAPH THERAPEUTICS
Kanaph Therapeutics is a biotech with activities that range from drug discovery to early-stage clinical trials. We are dedicated to developing next-generation therapeutics for oncology and autoimmune diseases. Our oncology pipeline includes bi-specific antibodies and small molecules that have a greatly enhanced immuno-stimulatory activity in the tumor microenvironment (TME) for efficient tumor eradication. Our autoimmune disease pipeline is composed of bispecific Fc-fusions that inhibit the alternative complement pathway while inhibiting angiogenesis and downstream complement activation as well.
KANAPH THERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2019-02-14
Address:
Yongsan, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.kanaphtx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
27 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Content Delivery Network Euro Google Maps JsDelivr AJAX Libraries API Pound Sterling
Current Employees Featured
Founder
Investors List
Time Folio Asset Management
Time Folio Asset Management investment in Series B - Kanaph Therapeutics
Green Cross
Green Cross investment in Series B - Kanaph Therapeutics
Kolon Investment
Kolon Investment investment in Series B - Kanaph Therapeutics
Time Folio Asset Management
Time Folio Asset Management investment in Series A - Kanaph Therapeutics
Meritz Securities
Meritz Securities investment in Series A - Kanaph Therapeutics
Official Site Inspections
http://www.kanaphtx.com
- Host name: 112.175.85.184
- IP address: 112.175.85.184
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
